AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.21B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.15B |
| 3 |
Quanta Services
PWR
|
+$691M |
| 4 |
Trane Technologies
TT
|
+$684M |
| 5 |
RTX Corp
RTX
|
+$655M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.74B |
| 2 |
Microsoft
MSFT
|
+$2.35B |
| 3 |
Broadcom
AVGO
|
+$744M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$636M |
| 5 |
TSMC
TSM
|
+$590M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.92% |
| 2 | Miscellaneous | 10.92% |
| 3 | Healthcare | 10.85% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3301
Agenus
AGEN
$286M
| $41.3K | ﹤0.01% |
+12,380
| New | +$44.4K |
2026 Q2
0 quarters
|
|
3302
Tigo Energy
TYGO
$79.1M
| $40.5K | ﹤0.01% |
+17,400
| New | +$65.5K |
2026 Q2
0 quarters
|
|
3303
Stereotaxis
STXS
$102M
| $40.1K | ﹤0.01% |
21,780
+8,000
| +58% | +$15K |
2025 Q2
4 quarters
|
|
3304
Zentalis Pharmaceuticals
ZNTL
$209M
| $40K | ﹤0.01% |
+17,100
| New | +$68.3K |
2026 Q2
0 quarters
|
|
3305
Prelude Therapeutics
PRLD
$290M
| $36K | ﹤0.01% |
+10,530
| New | +$45.8K |
2026 Q2
0 quarters
|
|
3306
Context Therapeutics
CNTX
$22M
| $32.7K | ﹤0.01% |
+59,000
| New | +$120K |
2026 Q2
0 quarters
|
|
3307
Galectin Therapeutics
GALT
$322M
| $31.2K | ﹤0.01% |
+11,200
| New | +$29K |
2026 Q2
0 quarters
|
|
3308
OPAL Fuels
OPAL
$45.7M
| $30.7K | ﹤0.01% |
+12,200
| New | +$26.8K |
2026 Q2
0 quarters
|
|
3309
Alpha Teknova
TKNO
$345M
| $29.2K | ﹤0.01% |
+10,100
| New | +$40.1K |
2026 Q2
0 quarters
|
|
3310
Inhibikase Therapeutics
IKT
$222M
| $25.7K | ﹤0.01% |
+15,320
| New | +$27.4K |
2026 Q2
0 quarters
|
|
3311
GoodRx Holdings
GDRX
$1.21B
| $25.3K | ﹤0.01% |
12,903
| – | – |
2025 Q3
3 quarters
|
|
3312
Tron Inc
TRON
$683M
| $21.6K | ﹤0.01% |
+13,400
| New | +$27.1K |
2026 Q2
0 quarters
|
|
3313
Playboy Inc
PLBY
$131M
| $21K | ﹤0.01% |
+13,800
| New | +$20.9K |
2026 Q2
0 quarters
|
|
3314
BuzzFeed
BZFD
$84.5M
| $16.3K | ﹤0.01% |
26,823
| – | – |
2021 Q4
18 quarters
|
|
3315
Hyperfine
HYPR
$76.8M
| $16K | ﹤0.01% |
+14,800
| New | +$21.4K |
2026 Q2
0 quarters
|
|
3316
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.62B
| – | – |
-293,420
| Closed | -$27.3M | – |
|
3317
DELISTED
Arcellx
ACLX
| – | – |
-544,227
| Closed | -$35.5M | – |
|
3318
AudioEye
AEYE
$102M
| – | – |
-13,380
| Closed | -$134K | – |
|
3319
Airship AI Holdings
AISP
$74.4M
| – | – |
-67,960
| Closed | -$196K | – |
|
3320
DELISTED
Air Lease Corp
AL
| – | – |
-417,668
| Closed | -$26.8M | – |
|
3321
Aldeyra Therapeutics
ALDX
$39.2M
| – | – |
-68,140
| Closed | -$353K | – |
|
3322
Alight
ALIT
$253M
| – | – |
-6,028
| Closed | -$235K | – |
|
3323
DELISTED
American Woodmark
AMWD
| – | – |
-832,053
| Closed | -$44.8M | – |
|
3324
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-638,291
| Closed | -$16M | – |
|
3325
Accuray
ARAY
$15.5M
| – | – |
-54,730
| Closed | -$45.1K | – |
|
Similar funds
AllianceBernstein's Q2 2026 Portfolio in Review
As of Q2 2026, AllianceBernstein held 3,456 positions worth $302B, down 2.1% from $309B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
AllianceBernstein withdrew a net $10.1B in Q2 2026, closing 139 positions and reducing 1,179 holdings. Its most notable exit was Hologic, an estimated $75.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, AllianceBernstein opened a new position in Honeywell Aerospace worth $183M.
- AllianceBernstein's largest Q2 2026 buy was Honeywell Aerospace: 827,059 shares worth $183M.
- AllianceBernstein added most to Micron Technology in Q2 2026, an estimated $1.21B increase.
- AllianceBernstein's biggest Q2 2026 reduction was Amazon, cutting an estimated $3.74B.
- AllianceBernstein fully exited Hologic in Q2 2026, selling an estimated $75.9M.
- AllianceBernstein's ten largest holdings make up 31% of its $302B portfolio in Q2 2026.
- AllianceBernstein opened 228 new positions and closed 139 in Q2 2026.
- AllianceBernstein's portfolio value fell 2.1% quarter-over-quarter to $302B.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.